Article

Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn

Uppsala University Hospital, Uppsala, Uppsala, Sweden
New England Journal of Medicine (Impact Factor: 54.42). 06/2006; 354(20):2188-90; author reply 2188-90.
Source: PubMed

ABSTRACT ABSTRACT Background Persistent pulmonary,hypertension of the newborn,(PPHN) is associated with sub- stantial infant mortality and morbidity. A previous cohort study suggested a pos- sible association between maternal use of the selective serotonin-reuptake inhibitor (SSRI) fluoxetine late in the third trimester of pregnancy and the risk of PPHN in the infant. Weperformed,a case–control study to assess whether PPHN is associated with exposure to SSRIs during late pregnancy. Methods

0 Followers
 · 
90 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The first example of the FBW rearrangement using of lanthanum metal and a catalytic amount of iodine was disclosed. When gem-diiodo- and gem-dibromoalkenes were treated with lanthanum metal in the presence of a catalytic amount of iodine, the reductive dehalogenation of these compounds smoothly proceeded to produce the corresponding alkynes in moderate to good yields.
    Journal of Organometallic Chemistry 05/2011; 696(9):1916-1919. DOI:10.1016/j.jorganchem.2011.02.014 · 2.30 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The effects of serotonin (5-hydroxytryptamine, 5-HT) on the pulmonary circulation attracted the interest of researchers when an increased risk of idiopathic pulmonary arterial hypertension (IPAH) was reported in patients who had used appetite suppressants that interact with 5-HT. An association between the anorexigen aminorex and IPAH was described in the 1960s. In the 1980s, fenfluramine use was shown to be associated with an epidemic of IPAH in France and Belgium. The 5-HT hypothesis received support from the observation that pulmonary hypertension (PH) develops spontaneously in fawn-hooded rats, which have an inherited platelet-storage defect. Early studies focused on circulating 5-HT and its potential effects on the pulmonary vascular bed. They showed that patients with IPAH had increased circulating 5-HT levels even after heart–lung transplantation. In addition to its vasoactive effects, 5-HT exerts mitogenic and comitogenic effects on pulmonary artery smooth muscle cells (PASMCs). In contrast to the constricting action of 5-HT on smooth muscle cells, which is mainly mediated by 5-HT receptors (5-HT1B/D, 5-HT2A, and 5-HT2B), the mitogenic and comitogenic effects of 5-HT require the internalization of indoleamine by the 5-HT transporter (5-HTT). Accordingly, drugs that competitively inhibit 5-HTT also block the mitogenic effects of 5-HT on smooth muscle cells. The appetite suppressants fenfluramine, d-fenfluramine, and aminorex differ from selective 5-HTT inhibitors in that they not only inhibit 5-HT reuptake, but also trigger indoleamine release and interact with 5-HTT and 5-HT receptors in a specific manner. Over the last few years, the role of the 5-HT pathway in the pathogenesis of PH has been extensively investigated, and severe alterations in several critical steps of this pathway have been found during the progression of PH. These alterations include changes in 5-HT synthesis and bioavailability, changes in 5-HT-mediating effects on target cells (PASMCs and fibroblasts), and alterations in intracellular signaling. These critical steps represent targets for future therapies and will be discussed individually.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Hypoxemic respiratory failure in the term newborn is still an important cause of morbidity and mortality during the first month of extrau - terine life. The most common causes are meconium aspiration syndrome (MAS), hyaline membrane syndrome, pneumonia/sepsis and pulmonary hypoplasia with or without congenital diaphragmatic hernia. Most of these diseases can become complicated with persistent pulmonary hypertension, making their treatment difficult. The echocardiographic findings for the diagnosis of pulmonary hypertension include an elevated pressure of the pulmonary artery and extrapulmonary right -to-left shunting of blood at the foramen ovale and/or the ductus arteriosus. We made a review about prenatal growth and development of the pulmonary circulation and the differences between hypoxia and hypoxemia.